10 likes | 285 Views
Table 5 Active large phase II–III trials of PARP inhibitors in BRCA -mutation carriers or patients with breast cancer. Sonnenblick, A. et al. ( 2014) An update on PARP inhibitors—moving to the adjuvant setting Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2014.163.
E N D
Table 5 Active large phase II–III trials of PARP inhibitors in BRCA-mutation carriers or patients with breast cancer Sonnenblick, A. et al. (2014) An update on PARP inhibitors—moving to the adjuvant setting Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2014.163